POMPANO BEACH, Fla., June 13, 2006 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced record results for May 2006 in gross billings and new patient shipments. MEDirect Latino reports gross billings of $1,294,852 during the month, a 12.6% increase over April billings of $1,150,413. The Company's gross product profit margins remained unchanged at 78%. Total new patient shipments for May numbered 6,499, an increase of 20.10% over April shipments of 5,411. The Company's 'patient hold journal' (approved and pending shipment for regulatory processing), closed the month with 7,599 additional customer orders, an increase of 23.4% over the April patient hold journal of 6,158. MEDirect Latino expects to monetize its approved and pending patient orders in May, which is typical to the Company's model.
Ms. Debra Towsley, President/CEO, MEDirect Latino stated, "MEDirect Latino's consistent double digit monthly revenue growth is driven by our proprietary methodologies in marketing and sales coupled with our demographically targeted product development. We have taken the time to understand what our customer wants and how they want to be serviced. The combination of our national media campaign and culturally specific customer care services prove to be the special ingredients for our recipe of success in quickly establishing MEDirect Latino with the largest Hispanic health care database of Medicare eligible customers in the country. The Company's relocation to a larger headquarters and operations center further enhances our customer acquisition platform. We will now scale our already proven model through the multi-million dollar sales per month range."
About MEDirect Latino:
MEDirect Latino (Pink Sheets:MLTO) (www.medirectlatino.org) is the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community. MEDirect Latino is rapidly growing and uniquely positioned to service the Hispanic community in the United States and Puerto Rico. MEDirect is the only company currently positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. Type II diabetes was targeted because of its unique status within the Medicare reimbursement regime and due to its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These and other conditions represent considerable future market potential, MEDirect will scale its model by leveraging its existing client base and infrastructure in introducing new products and services to existing customers as they are identified.
The MEDirect Latino Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure:
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.